Globus Medical Inc. (GMED), a musculoskeletal implant maker, on Tuesday said it expects to report fourth-quarter sales of about $128.5 million, an 11.5% from a year ago.
Analysts polled by Thomson Reuters currently expect the company to report sales of about $121.9 million for the quarter.
For the full year 2014, the company estimates sales of $474 million, up 9.1 percent from a year ago, and above its prior guidance range of $462 million to 467 million.
Analysts currently expect the company to report sales of $467.6 million for 2014.
For fiscal year 2015, the company expects earnings of about $1.01 per share on sales of about $510 million.
Analysts expect earnings of $1.02 per share on revenues of $514.4 million for 2015.
"In 2014, we continued to focus on growing our business through the expansion of our sales force and the release of 16 innovative products. We also continued to invest significantly in our robotics division," said David Paul, the company's CEO.
"Looking to 2015, we are confident in our ability to continue to grow our business faster than the overall spine market while maintaining industry-leading profitability."
For comments and feedback contact: editorial@rttnews.com
Business News